Morgan Stanley downgrades Pfizer, says Mylan sale this week revealed some bad news
July 30, 2019 at 07:58 AM EDT
Morgan Stanley downgraded Pfizer to equal-weight from overweight and slashed it price target to $40 per share from $48 per share.
